Skip to main content
SpringerLink
Log in
Book cover

Fundamentals of Cancer Prevention pp 277–314Cite as

Prostate Cancer Prevention

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abate-Shen, C. and M.M. Shen (2000). "Molecular genetics of prostate cancer." Genes Dev 14(19): 2410–2434.

    Article  PubMed  Google Scholar 

  • Agarwal, R. (2000). "Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents." Biochem Pharmacol 60(8): 1051–1059.

    Article  PubMed  Google Scholar 

  • Alsikafi, N.F., C.B. Brendler, et al. (2001). "High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone." Urology 57(2): 296–300.

    Article  PubMed  Google Scholar 

  • Andriole, G.L. and W.J. Catalona (1993). "Using PSA to screen for prostate cancer. The Washington University experience." Urol Clin North Am 20(4): 647–651.

    PubMed  Google Scholar 

  • Apakama, I., M.C. Robinson, et al. (1996). "bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer." Br J Cancer 74(8): 1258–1262.

    PubMed  Google Scholar 

  • Aspden, W.J., R.J. Rodgers, et al. (1998). "Changes in testicular steroidogenic acute regulatory (STAR) protein, steroidogenic enzymes and testicular morphology associated with increased testosterone secretion in bulls receiving the luteinizing hormone releasing hormone agonist deslorelin." Domest Anim Endocrinol 15(4): 227–238.

    Article  PubMed  Google Scholar 

  • Baldwin, A.S., Jr. (1996). "The NF-kappa B and I kappa B proteins: new discoveries and insights." Annu Rev Immunol 14: 649–683.

    Article  PubMed  Google Scholar 

  • Banerjee, A.G., J. Liu, et al. (2003). "Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA." Mol Cancer 2(1): 34.

    Article  PubMed  Google Scholar 

  • Barqawi, A., I.M. Thompson, et al. (2004). "Prostate cancer chemoprevention: an overview of United States trials." J Urol 171(2 Pt 2): S5–8; discussion S9.

    Article  PubMed  Google Scholar 

  • Bartels, P.H., R. Montironi, et al. (1998). "Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma." Anal Quant Cytol Histol 20(5): 389–396.

    PubMed  Google Scholar 

  • Bartels, P.H., R. Montironi, et al. (1998). "Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes." Anal Quant Cytol Histol 20(5): 397–406.

    PubMed  Google Scholar 

  • Beilin, J., L. Harewood, et al. (2001). "A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects." Cancer 92(4): 941–949.

    Article  PubMed  Google Scholar 

  • Bishop, M.C. (2000). "Trends in prostate cancer mortality in England, Wales, and the USA." Lancet Oncol 1(1): 14.

    Article  Google Scholar 

  • Borboroglu, P.G., S.W. Comer, et al. (2000). "Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies." J Urol 163(1): 158–162.

    Article  PubMed  Google Scholar 

  • Bost, K.L. and M.J. Mason (1995). "Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages." J Immunol 155(1): 285–296.

    PubMed  Google Scholar 

  • Bostwick, D.G. (2000). "Prostatic intraepithelial neoplasia." Curr Urol Rep 1(1): 65–70.

    PubMed  Google Scholar 

  • Bours, V., M. Bentires-Alj, et al. (2000). "Nuclear factor-kappa B, cancer, and apoptosis." Biochem Pharmacol 60(8): 1085–1089.

    Article  PubMed  Google Scholar 

  • Burks, D.A. and R.H. Littleton (1992). "The epidemiology of prostate cancer in black men." Henry Ford Hosp Med J 40(1–2): 89–92.

    PubMed  Google Scholar 

  • Cabeza-Arvelaiz, Y., J.L. Sepulveda, et al. (2001). "Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22." Oncogene 20(31): 4169–4179.

    Article  PubMed  Google Scholar 

  • Carroll, P.R. (2003). "Trends in prostate cancer mortality among black men and white men in the United States. Chu KC, Tarone RE, Freeman HP, Center to Reduce Cancer Health Disparities, National Cancer Institute, Bethesda, MD. Cancer 2003;97:1507–1516." Urol Oncol 21(6): 483–484.

    Google Scholar 

  • Carty, S.E., C.M. Buresh, et al. (1991). "Decreased IL-6 secretion by fibroblasts following repeated doses of TNF alpha or IL-1 alpha: post-transcriptional gene regulation." J Surg Res 51(1): 24–32.

    Article  PubMed  Google Scholar 

  • Cassidy, A. (2003). "Potential risks and benefits of phytoestrogen-rich diets." Int J Vitam Nutr Res 73(2): 120–126.

    PubMed  Google Scholar 

  • Catalona, W.J., J.P. Richie, et al. (1994). "Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves." J Urol 152(6 Pt 1): 2031–2036.

    PubMed  Google Scholar 

  • Chun, Y.J., M.Y. Kim, et al. (1999). "Resveratrol is a selective human cytochrome P450 1A1 inhibitor." Biochem Biophys Res Commun 262(1): 20–24.

    Article  PubMed  Google Scholar 

  • Chung, T.D., J.J. Yu, et al. (1999). "Characterization of the role of IL-6 in the progression of prostate cancer." Prostate 38(3): 199–207.

    Article  PubMed  Google Scholar 

  • Clark, L.C., G.F. Combs, Jr., et al. (1996). "Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group." JAMA 276(24): 1957–1963.

    Article  PubMed  Google Scholar 

  • Clark, L.C. and E.T. Jacobs (1998). "Environmental selenium and cancer: risk or protection" Cancer Epidemiol Biomarkers Prev 7(10): 847–848; discussion 851–852.

    PubMed  Google Scholar 

  • Clegg, L.X., F.P. Li, et al. (2002). "Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study." Arch Intern Med 162(17): 1985–1993.

    Article  PubMed  Google Scholar 

  • Cronauer, M.V., W.A. Schulz, et al. (2003). "The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review)." Int J Oncol 23(4): 1095–1102.

    PubMed  Google Scholar 

  • Delmas, D., C. Rebe, et al. (2003). "Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells." J Biol Chem 278(42): 41482–41490.

    Article  PubMed  Google Scholar 

  • Dessypris, A.G. (1975). "Testosterone sulphate, its biosynthesis, metabolism, measurement, functions and properties." J Steroid Biochem 6(8): 1287–1298.

    Article  PubMed  Google Scholar 

  • Dhanalakshmi, S., P. Agarwal, et al. (2003). "Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin-and carboplatin-induced growth inhibition and apoptotic death." Int J Cancer 106(5): 699–705.

    Article  PubMed  Google Scholar 

  • Djavan, B., A. Zlotta, et al. (2000). "Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men." J Urol 163(4): 1144–1148; discussion 1148–1149.

    Article  PubMed  Google Scholar 

  • Duffield-Lillico, A.J., B.L. Dalkin, et al. (2003). "Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial." BJU Int 91(7): 608–612.

    Article  PubMed  Google Scholar 

  • Durkan, G.C. and D.R. Greene (1999). "Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?" BJU Int 83(1): 34–38.

    Article  Google Scholar 

  • Eastham, J.A., R.A. May, et al. (1998). "Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer." J Natl Cancer Inst 90(10): 756–760.

    Article  PubMed  Google Scholar 

  • Ellis, W.J. and M.K. Brawer (1995). "Repeat prostate needle biopsy: who needs it?" J Urol 153(5): 1496–1498.

    Article  PubMed  Google Scholar 

  • Erbersdobler, A., H. Fritz, et al. (2002). "Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone." Eur Urol 41(1): 40–46.

    Article  PubMed  Google Scholar 

  • Etzioni, R., K.M. Berry, et al. (2002). "Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991–1998." Urology 59(2): 251–255.

    Article  PubMed  Google Scholar 

  • Fleshner, N.E., M. O'Sullivan, et al. (1997). "Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate." J Urol 158(2): 505–508; discussion 508–509.

    Article  PubMed  Google Scholar 

  • Fosslien, E. (2001). "Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis." Ann Clin Lab Sci 31(4): 325–348.

    PubMed  Google Scholar 

  • Fowler, J.E., Jr., S.A. Bigler, et al. (2001). "Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race." Cancer 91(7): 1291–1296.

    Article  PubMed  Google Scholar 

  • Fowler, J.E., Jr., S.A. Bigler, et al. (2000). "Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer." J Urol 163(3): 813–818.

    Article  PubMed  Google Scholar 

  • Gasparian, A.V., Y.J. Yao, et al. (2002). "Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells." Mol Cancer Ther 1(12): 1079–1087.

    PubMed  Google Scholar 

  • Gerber, G.S. (2000). "Saw palmetto for the treatment of men with lower urinary tract symptoms." J Urol 163(5): 1408–1412.

    Article  PubMed  Google Scholar 

  • Gerber, G.S., D. Kuznetsov, et al. (2001). "Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms." Urology 58(6): 960–964; discussion 964–965.

    Article  PubMed  Google Scholar 

  • Giovannucci, E. and E. Platz (2002). Nutritional and Environmental Epidemiology of Prostate Cancer. Prostate Cancer Principles and Practice, Lippincott Williams & Wilkins, 8th Edition: 117–139.

    Google Scholar 

  • Godbey, W.T. and A. Atala (2003). "Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery." Gene Ther 10(17): 1519–1527.

    Article  PubMed  Google Scholar 

  • Goldmann, W.H., A.L. Sharma, et al. (2001). "Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells." Cell Biol Int 25(11): 1117–1124.

    Article  PubMed  Google Scholar 

  • Gross, A., J.M. McDonnell, et al. (1999). "BCL-2 family members and the mitochondria in apoptosis." Genes Dev 13(15): 1899–1911.

    PubMed  Google Scholar 

  • Guinan, P., N. Gilham, et al. (1981). "What is the best test to detect prostate cancer?" CA Cancer J Clin 31(3): 141–145.

    PubMed  Google Scholar 

  • Henshall, S.M., D.I. Quinn, et al. (2001). "Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients." Clin Cancer Res 7(3): 544–550.

    PubMed  Google Scholar 

  • Hilbert, D.M., M. Kopf, et al. (1995). "Interleukin 6 is essential for in vivo development of B lineage neoplasms." J Exp Med 182(1): 243–248.

    Article  PubMed  Google Scholar 

  • Holund, B. (1980). "Latent prostatic cancer in a consecutive autopsy series." Scand J Urol Nephrol 14(1): 29–35.

    PubMed  Google Scholar 

  • Hsing, A.W., Y.T. Gao, et al. (2000). "Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China." Cancer Res 60(18): 5111–5116.

    PubMed  Google Scholar 

  • Hsu, A.L., T.T. Ching, et al. (2000). "The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2." J Biol Chem 275(15): 11397–11403.

    Article  PubMed  Google Scholar 

  • Hzyek (1995). "Prostate Biopsy Rates." Curr Opinion in Urology 9(371).

    Google Scholar 

  • Iczkowski, K.A., C.G. Pantazis, et al. (2002). "Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma." Cancer 95(12): 2487–2493.

    Article  PubMed  Google Scholar 

  • Imai, K., Y. Ichinose, et al. (1994). "Clinical significance of prostate specific antigen for early stage prostate cancer detection." Jpn J Clin Oncol 24(3): 160–165.

    PubMed  Google Scholar 

  • Imai, M., H.Y. Hwang, et al. (2004). "The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo." Immunology 111(3): 291–297.

    Article  PubMed  Google Scholar 

  • Irvine, R.A., M.C. Yu, et al. (1995). "The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer." Cancer Res 55(9): 1937–1940.

    PubMed  Google Scholar 

  • Jang, M., L. Cai, et al. (1997). "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes." Science 275(5297): 218–220.

    Article  PubMed  Google Scholar 

  • Jemal, A., R.C. Tiwari, et al. (2004). "Cancer statistics, 2004." CA Cancer J Clin 54(1): 8–29.

    PubMed  Google Scholar 

  • Jiang, C., Z. Wang, et al. (2001). "Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells." Cancer Res 61(7): 3062–3070.

    PubMed  Google Scholar 

  • Jirik, F.R., T.J. Podor, et al. (1989). "Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells." J Immunol 142(1): 144–147.

    PubMed  Google Scholar 

  • Johnson, A.J., X. Song, et al. (2001). "Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells." Adv Enzyme Regul 41: 221–235.

    Article  PubMed  Google Scholar 

  • Johnson, M.I. and F.C. Hamdy (1998). "Apoptosis regulating genes in prostate cancer (review)." Oncol Rep 5(3): 553–557.

    PubMed  Google Scholar 

  • Johnson, M.I., M.C. Robinson, et al. (1998). "Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation." Prostate 37(4): 223–229.

    Article  PubMed  Google Scholar 

  • Kagan, J., J. Stein, et al. (1995). "Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes." Oncogene 11(10): 2121–2126.

    PubMed  Google Scholar 

  • Kamijo, T., T. Sato, et al. (2001). "Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines." Int J Urol 8(7): S35–39.

    Article  PubMed  Google Scholar 

  • Kamoi, K., P. Troncoso, et al. (2000). "Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia." J Urol 163(3): 819–823.

    Article  PubMed  Google Scholar 

  • Kapadia, G.J., M.A. Azuine, et al. (2002). "Inhibitory effect of herbal remedies on 12-O-tetra-decanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation." Pharmacol Res 45(3): 213–220.

    Article  PubMed  Google Scholar 

  • Katoh, M. (2002). "Expression of human SOX7 in normal tissues and tumors." Int J Mol Med 9(4): 363–368.

    PubMed  Google Scholar 

  • Katoh, M. (2002). "Molecular cloning and characterization of human SOX17." Int J Mol Med 9(2): 153–157.

    PubMed  Google Scholar 

  • Keetch, D.W., W.J. Catalona, et al. (1994). "Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values." J Urol 151(6): 1571–1574.

    PubMed  Google Scholar 

  • Kirschenbaum, A., X. Liu, et al. (2001). "The role of cyclooxygenase-2 in prostate cancer." Urology 58(2 Suppl 1): 127–131.

    Article  PubMed  Google Scholar 

  • Klein, E.A., I.M. Thompson, et al. (2000). "SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design." Prostate Cancer Prostatic Dis 3(3): 145–151.

    Article  PubMed  Google Scholar 

  • Klein, E.A., I.M. Thompson, et al. (2001). "SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial." J Urol 166(4): 1311–1315.

    Article  PubMed  Google Scholar 

  • Knaus, J. (2002). "Saw palmetto for BPH symptoms." Adv Nurse Pract 10(6): 26–27.

    Google Scholar 

  • Knol, B.W. and S.T. Egberink-Alink (1989). "Androgens, progestagens and agonistic behaviour: a review." Vet Q 11(2): 94–101.

    PubMed  Google Scholar 

  • Kunimi, K., U.S. Bergerheim, et al. (1991). "Allelotyping of human prostatic adenocarcinoma." Genomics 11(3): 530–536.

    Article  PubMed  Google Scholar 

  • Lee, H.L., K.J. Pienta, et al. (2003). "The effect of bone-associated growth factors and cyto-kines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro." Int J Oncol 22(4): 921–926.

    PubMed  Google Scholar 

  • Lee, M.M., S.L. Gomez, et al. (2003). "Soy and isoflavone consumption in relation to prostate cancer risk in China." Cancer Epidemiol Biomarkers Prev 12(7): 665–668.

    PubMed  Google Scholar 

  • Lee, S.O., W. Lou, et al. (2003). "Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells." Clin Cancer Res 9(1): 370–376.

    PubMed  Google Scholar 

  • Letran, J.L., A.B. Blase, et al. (1998). "Repeat ultrasound guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma." J Urol 160(2): 426–429.

    Article  PubMed  Google Scholar 

  • Levine, M.A., M. Ittman, et al. (1998). "Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer." J Urol 159(2): 471–475; discussion 475–476.

    Article  PubMed  Google Scholar 

  • Lim, J.T., G.A. Piazza, et al. (1999). "Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines." Biochem Pharmacol 58(7): 1097–1107.

    Article  PubMed  Google Scholar 

  • Liu, X.H., A. Kirschenbaum, et al. (2000). "Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo." J Urol 164(3 Pt 1): 820–825.

    Article  PubMed  Google Scholar 

  • Liu, X.H., S. Yao, et al. (1998). "NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells." Cancer Res 58(19): 4245–4249.

    PubMed  Google Scholar 

  • Lokeshwar, B.L. (1999). "MMP inhibition in prostate cancer." Ann NY Acad Sci 878: 271–289.

    PubMed  Google Scholar 

  • Lui, P.D., M.K. Terris, et al. (1995). "Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer." J Urol 153(3 Pt 2): 1000–1003.

    Article  PubMed  Google Scholar 

  • Maliner-Stratton, M.S., R.D. Klein, et al. (2001). "Interleukin-1 beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP." Neoplasia 3(6): 509–520.

    Article  PubMed  Google Scholar 

  • Marshall, J.R. (2001). "High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research." IARC Sci Publ 154: 191–198.

    PubMed  Google Scholar 

  • Mason, M.D., G. Davies, et al. (2002). "Cell adhesion molecules and adhesion abnormalities in prostate cancer." Crit Rev Oncol Hematol 41(1): 11–28.

    PubMed  Google Scholar 

  • McDonnell, T.J., P. Troncoso, et al. (1992). "Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer." Cancer Res 52(24): 6940–6944.

    PubMed  Google Scholar 

  • Mercurio, F. and A.M. Manning (1999). "NF-kappaB as a primary regulator of the stress response." Oncogene 18(45): 6163–6171.

    Article  PubMed  Google Scholar 

  • Merseburger, A.S., M.A. Kuczyk, et al. (2003). "Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues." Oncol Rep 10(1): 223–228.

    PubMed  Google Scholar 

  • Miller, E.A., J.L. Stanford, et al. (2001). "Polymorphic repeats in the androgen receptor gene in high-risk sibships." Prostate 48(3): 200–205.

    Article  PubMed  Google Scholar 

  • Miltyk, W., C.N. Craciunescu, et al. (2003). "Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer." Am J Clin Nutr 77(4): 875–882.

    PubMed  Google Scholar 

  • Mitchell, S.H., W. Zhu, et al. (1999). "Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells." Cancer Res 59(23): 5892–5895.

    PubMed  Google Scholar 

  • Mononen, N., K. Syrjakoski, et al. (2000). "Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene." Cancer Res 60(22): 6479–6481.

    PubMed  Google Scholar 

  • Moody, T.W., J. Leyton, et al. (1998). "Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth." Exp Lung Res 24(4): 617–628.

    PubMed  Google Scholar 

  • Mori, S., K. Murakami-Mori, et al. (1999). "Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor." Anticancer Res 19(2A): 1011–1015.

    PubMed  Google Scholar 

  • Mundy, G.R. (1997). "Mechanisms of bone metastasis." Cancer 80(8 Suppl): 1546–1556.

    Article  PubMed  Google Scholar 

  • Nakagawa, H., Y. Kiyozuka, et al. (2001). "Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator." J Cancer Res Clin Oncol 127(4): 258–264.

    Article  PubMed  Google Scholar 

  • Narla, G., K.E. Heath, et al. (2001). "KLF6, a candidate tumor suppressor gene mutated in prostate cancer." Science 294(5551): 2563–2566.

    Article  PubMed  Google Scholar 

  • NCI (2004). PDQ® Clinical Trials Database, National Cancer Institute. http://www.cancer.gov/search/clinical_trails/, Accessed Feb 8, 2005.

    Google Scholar 

  • NCI (2004). SEER Database. http://seer.cancer.gov, Accessed Feb 8, 2005.

    Google Scholar 

  • Nelson, M.A., M. Reid, et al. (2002). "Prostate cancer and selenium." Urol Clin North Am 29(1): 67–70.

    Article  PubMed  Google Scholar 

  • Niles, R.M., M. McFarland, et al. (2003). "Resveratrol is a potent inducer of apoptosis in human melanoma cells." Cancer Lett 190(2): 157–163.

    Article  PubMed  Google Scholar 

  • Oleksowicz, L. and J.P. Dutcher (1994). "A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12." Am J Ther 1(2): 107–115.

    PubMed  Google Scholar 

  • O'Shaughnessy, C., E. Prosser, et al. (1996). "Differential stimulation of IL-6 secretion following apical and basolateral presentation of IL-1 on epithelial cell lines." Biochem Soc Trans 24(1): 83S.

    Google Scholar 

  • Oshima, M., J.E. Dinchuk, et al. (1996). "Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)." Cell 87(5): 803–809.

    Article  PubMed  Google Scholar 

  • Oshima, M., H. Sugiyama, et al. (1993). "APC gene messenger RNA: novel isoforms that lack exon 7." Cancer Res 53(23): 5589–5591.

    PubMed  Google Scholar 

  • Ostrander, E.A. and J.L. Stanford (2000). "Genetics of prostate cancer: too many loci, too few genes." Am J Hum Genet 67(6): 1367–1375.

    Article  PubMed  Google Scholar 

  • Overvad, K. (1998). "Selenium and cancer." Bibl Nutr Dieta(54): 141–149.

    PubMed  Google Scholar 

  • Panaiotov, D. (1978). "[Testosterone, its biosynthesis, transport and metabolism]." Vutr Boles 17(4): 15–21.

    Google Scholar 

  • Park, S.J., H. Miyake, et al. (2003). "Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy." Int J Urol 10(2): 68–71.

    Article  PubMed  Google Scholar 

  • Perachino, M., L. di Ciolo, et al. (1997). "Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels." Eur Urol 32(2): 155–159.

    PubMed  Google Scholar 

  • Pollack, A., D. Cowen, et al. (2003). "Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x." Cancer 97(7): 1630–1638.

    Article  PubMed  Google Scholar 

  • Prasad, S., P. Thraves, et al. (1998). "Cytoskeletal and adhesion protein changes during neoplastic progression of human prostate epithelial cells." Crit Rev Oncol Hematol 27(1): 69–79.

    PubMed  Google Scholar 

  • Presti, J.C. (2002). Systemic Biopsy of the Prostate: Applications for Detection, Staging and Risk Assessment. Prostate Cancer Principles and Practice, Lippencott Williams & Wilkins, 16:225–231.

    Google Scholar 

  • Pruthi, R.S., J.E. Derksen, et al. (2004). "A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy." BJU Int 93(3): 275–278.

    Article  PubMed  Google Scholar 

  • Qian, J., R.B. Jenkins, et al. (1997). "Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization." Mod Pathol 10(11): 1113–1119.

    PubMed  Google Scholar 

  • Quinn, M. and P. Babb (2002). "Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries." BJU Int 90(2): 174–184.

    Article  PubMed  Google Scholar 

  • Raap, T., H.P. Justen, et al. (2000). "Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis." J Rheumatol 27(11): 2558–2565.

    PubMed  Google Scholar 

  • Raffo, A.J., H. Perlman, et al. (1995). "Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo." Cancer Res 55(19): 4438–4445.

    PubMed  Google Scholar 

  • Reddy, B.S. and C.V. Rao (2000). "Colon cancer: a role for cyclooxygenase-2-specific nonsteroidal anti-inflammatory drugs." Drugs Aging 16(5): 329–334.

    PubMed  Google Scholar 

  • Reed, J.C., T. Miyashita, et al. (1996). "BCL-2 family proteins: regulators of cell death involved in the pathogencsis of cancer and resistance to therapy." J Cell Biochem 60(1): 23–32.

    Article  PubMed  Google Scholar 

  • Rietbergen, J.B. and F.H. Schroder (1998). "Screening for prostate cancer — more questions than answers." Acta Oncol 37(6): 515–532.

    Article  PubMed  Google Scholar 

  • Roehrborn, C.G., A. Gregory, et al. (1996). "Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology." Urology 48(6A Suppl): 23–32.

    Article  PubMed  Google Scholar 

  • Ross, J.S., C.E. Sheehan, et al. (2002). "Prognostic markers in prostate cancer." Expert Rev Mol Diagn 2(2): 129–142.

    Article  PubMed  Google Scholar 

  • Rosser, C.J., A.O. Reyes, et al. (2003). "Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma." Int J Radiat Oncol Biol Phys 56(1): 1–6.

    Article  PubMed  Google Scholar 

  • Rovner, E.S., F.J. Schanne, et al. (1997). "Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies." J Urol 158(1): 138–141; discussion 141–142.

    Article  PubMed  Google Scholar 

  • Royuela, M., M. Ricote, et al. (2004). "Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate." J Pathol 202(1): 41–49.

    Article  PubMed  Google Scholar 

  • Sakr, W.A., D.J. Grignon, et al. (1996). "Age and racial distribution of prostatic intraepithelial neoplasia." Eur Urol 30(2): 138–144.

    PubMed  Google Scholar 

  • Sakr, W.A. and A.W. Partin (2001). "Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia." Urology 57(4 Suppl 1): 115–120.

    Article  Google Scholar 

  • Sarma, A.V. and D. Schottenfeld (2002). "Prostate cancer incidence, mortality, and survival trends in the United States: 1981–2001." Semin Urol Oncol 20(1): 3–9.

    Article  PubMed  Google Scholar 

  • Scarlatti, F., G. Sala, et al. (2003). "Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling." Faseb J 17(15): 2339–2341.

    PubMed  Google Scholar 

  • Schaid, D.J. (2004). "The Complex Genetic Epidemiology of Prostate Cancer." Hum Mol Genet.

    Google Scholar 

  • Schiavi, R.C. and D. White (1976). "Androgens and male sexual function: a review of human studies." J Sex Marital Ther 2(3): 214–228.

    PubMed  Google Scholar 

  • Sellers, W.R. and D.E. Fisher (1999). "Apoptosis and cancer drug targeting." J Clin Invest 104(12): 1655–1661.

    PubMed  Google Scholar 

  • Shamberger, R.J. and D.V. Frost (1969). "Possible protective effect of selenium against human cancer." Can Med Assoc J 100(14): 682.

    PubMed  Google Scholar 

  • Sharifi, R., W.B. Waters, et al. (1981). "Diagnosis of cancer of the prostate." Curr Surg 38(5): 297–299.

    PubMed  Google Scholar 

  • Singh, R.P., S. Dhanalakshmi, et al. (2002). "Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels." Cancer Res 62(11): 3063–3069.

    PubMed  Google Scholar 

  • Slater, S.J., J.L. Seiz, et al. (2003). "Inhibition of protein kinase C by resveratrol." Biochim BiophysActa 1637(1): 59–69.

    Google Scholar 

  • Soderquist, B., J. Kallman, et al. (1998). "Secretion of IL-6, IL-8 and G-CSF by human endothelial cells in vitro in response to Staphylococcus aureus and staphylococcal exotoxins." Apmis 106(12): 1157–1164.

    PubMed  Google Scholar 

  • Spiotto, M.T. and T.D. Chung (2000). "STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP." Prostate 42(2): 88–98.

    Article  PubMed  Google Scholar 

  • Spiotto, M.T. and T.D. Chung (2000). "STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells." Prostate 42(3): 186–195.

    Article  PubMed  Google Scholar 

  • Stephenson, R.A. (2002). "Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database." Urol Clin North Am 29(1): 173–181.

    Article  PubMed  Google Scholar 

  • Stewart, C.S., B.C. Leibovich, et al. (2001). "Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies." J Urol 166(1): 86–91; discussion 91–92.

    Article  PubMed  Google Scholar 

  • Stewart, J.R., K.L. Christman, et al. (2000). "Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation." Biochem Pharmacol 60(9): 1355–1359.

    Article  PubMed  Google Scholar 

  • Stewart, J.R., N.E. Ward, et al. (1999). "Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism." Biochemistry 38(40): 13244–13251.

    Article  PubMed  Google Scholar 

  • Stratton, M.S. and F.R. Ahmann (2003). Molecular Mechanisms of Selenium and Prostate Cancer Chemoprevention. National Biotechnology in the Feed and Food Industry. P. Lyons. London, Nottingham Press. 1: 31–51.

    Google Scholar 

  • Stratton, M.S., M.E. Reid, et al. (2003). "Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study." Anticancer Drugs 14(8): 595–600.

    Article  PubMed  Google Scholar 

  • Stratton, M.S., M.E. Reid, et al. (2003). "Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study." Anticancer Drugs 14(8): 589–594.

    Article  PubMed  Google Scholar 

  • Subbaramaiah, K., W.J. Chung, et al. (1998). "Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells." J Biol Chem 273(34): 21875–21882.

    Article  PubMed  Google Scholar 

  • Sun, Y. and L.W. Oberley (1996). "Redox regulation of transcriptional activators." Free Radic Biol Med 21(3): 335–348.

    Article  PubMed  Google Scholar 

  • Sun, Z. and R. Andersson (2002). "NF-kappaB activation and inhibition: a review." Shock 18(2): 99–106.

    Article  PubMed  Google Scholar 

  • Surh, Y.J., K.S. Chun, et al. (2001). "Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation." Mutat Res 480–481: 243–268.

    PubMed  Google Scholar 

  • Tang, X., Y.J. Sun, et al. (2002). "Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells." Cancer Res 62(17): 4903–4908.

    PubMed  Google Scholar 

  • Taylor, J.A., 3rd, K.J. Gancarczyk, et al. (2002). "Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer." Urology 60(5): 841–845.

    Article  PubMed  Google Scholar 

  • Thompson, I.M., P.J. Goodman, et al. (2003). "The influence of finasteride on the development of prostate cancer." N Engl J Med 349(3): 215–224.

    Article  PubMed  Google Scholar 

  • Thun, M.J., M.M. Namboodiri, et al. (1993). "Aspirin use and risk of fatal cancer." Cancer Res 53(6): 1322–1327.

    PubMed  Google Scholar 

  • Tsujimoto, Y. and C.M. Croce (1986). "Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma." Proc Natl Acad Sci USA 83(14): 5214–5218.

    PubMed  Google Scholar 

  • Tyagi, A.K., R.P. Singh, et al. (2002). "Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis." Clin Cancer Res 8(11): 3512–3519.

    PubMed  Google Scholar 

  • Ukimura, O., O. Durrani, et al. (1997). "Role of PSA and its indices in determining the need for repeat prostate biopsies." Urology 50(1): 66–72.

    Article  PubMed  Google Scholar 

  • Veltri, R.W., L.S. Marks, et al. (2002). "Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism." Urology 60(4): 617–622.

    Article  PubMed  Google Scholar 

  • Vermeulen, A. (1991). "Clinical review 24: Androgens in the aging male." J Clin Endocrinol Metab 73(2): 221–224.

    PubMed  Google Scholar 

  • Westin, P. and A. Bergh (1998). "Apoptosis and other mechanisms in androgen ablation treatment and androgen independent progression of prostate cancer: a review." Cancer Detect Prev 22(5): 476–484.

    PubMed  Google Scholar 

  • Wilasrusmee, C., S. Kittur, et al. (2002). "Immunostimulatory effect of Silybum Marianum (milk thistle) extract." Med Sci Monit 8(11): BR439–443.

    PubMed  Google Scholar 

  • Wilt, T.J., A. Ishani, et al. (1998). "Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review." JAMA 280(18): 1604–1609.

    Article  PubMed  Google Scholar 

  • Winters, S.J., A. Brufsky, et al. (2001). "Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men." Metabolism 50(10): 1242–1247.

    Article  PubMed  Google Scholar 

  • Wise, G.J., V.K. Marella, et al. (2000). "Cytokine variations in patients with hormone treated prostate cancer." J Urol 164(3 Pt 1): 722–725.

    Article  PubMed  Google Scholar 

  • Witkamp, R. and M. Monshouwer (2000). "Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review." Vet Q 22(1): 11–16.

    PubMed  Google Scholar 

  • Wolter, F., B. Akoglu, et al. (2001). "Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines." J Nutr 131(8): 2197–2203.

    PubMed  Google Scholar 

  • Xie, W., Y.C. Wong, et al. (2000). "Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat." Prostate 44(1): 31–39.

    Article  PubMed  Google Scholar 

  • Xu, J., J.A. Stolk, et al. (2000). "Identification of differentially expressed genes in human prostate cancer using subtraction and microarray." Cancer Res 60(6): 1677–1682.

    PubMed  Google Scholar 

  • Yu, L., Z.J. Sun, et al. (2003). "Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer." World J Gastroenterol 9(10): 2341–2343.

    PubMed  Google Scholar 

  • Zellweger, T., C. Ninck, et al. (2003). "Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer." Prostate 55(1): 20–29.

    Article  Google Scholar 

  • Zi, X. and R. Agarwal (1999). "Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention." Proc Natl Acad Sci USA 96(13): 7490–7495.

    Article  PubMed  Google Scholar 

  • Zi, X., J. Zhang, et al. (2000). "Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells." Cancer Res 60(20): 5617–5620.

    PubMed  Google Scholar 

  • Zucker, S., M. Hymowitz, et al. (1999). "Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications." Ann NY Acad Sci 878: 212–227.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, University of Arizona, Tucson, AZ, 85724

    Suzanne Stratton & Frederick Ahmann

Authors
  1. Suzanne Stratton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederick Ahmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Prevention and Control, Arizona Cancer Center, 1515 N. Campbell Avenue, PO Box 245024, Tuscon, AZ, 85724

    David S. Alberts  & Lisa M. Hess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Stratton, S., Ahmann, F. (2005). Prostate Cancer Prevention. In: Alberts, D.S., Hess, L.M. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26337-3_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-26337-3_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24212-3

  • Online ISBN: 978-3-540-26337-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation